San Diego, CA, United States of America

Danielle M Lehsten


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Danielle M. Lehsten: Innovator in Cancer Treatment**

Introduction

Danielle M. Lehsten, based in San Diego, California, is an accomplished inventor with a keen focus on developing therapeutic solutions for critical health conditions. With her innovative spirit, she has contributed significantly to the field of oncology and infectious disease treatment.

Latest Patents

Danielle holds a notable patent for "Phosphoramidate Compounds and Methods of Use." This groundbreaking invention presents compounds, compositions, and methodologies aimed at treating cancer, infectious diseases, autoimmune disorders, and inflammatory conditions. The therapeutic compounds involved in her patent include 5'-phosphoramidatyl, 1,5-substituted pyrimidine compounds, as well as their derivatives, analogs, and pharmaceutically acceptable salts.

Career Highlights

Lehsten is affiliated with Celmed Oncology, a prominent company focused on cancer therapeutics. Her role there has allowed her to leverage her expertise in developing innovative treatment options that could potentially save lives and improve patient outcomes. The impact of her work speaks volumes about her dedication to advancing medical science.

Collaborations

Collaboration plays a crucial role in innovation, and Danielle is fortunate to work alongside esteemed colleagues such as H. Michael Shepard and Andrew Vaino. Together, they contribute to a dynamic research environment that fosters the development of effective therapies.

Conclusion

Danielle M. Lehsten's contributions to the field of medicine through her patented inventions highlight her as a leading figure in the fight against serious health conditions. With her unwavering commitment to innovation, she continues to pave the way for future breakthroughs in medical treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…